The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...
New technology enables the insertion of a large segment of DNA into a genome, potentially expanding gene therapy treatment ...
Organisms have been evolving to adapt to changing environmental conditions ever since life on Earth began. Those species that ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Topline results from the pivotal HAELO trial demonstrate that a single infusion of lonvo-z significantly reduces HAE attacks and the need for chronic prophylactic therapy.
A massive study of ancient and modern DNA from thousands of West Eurasian people has identified nearly 500 genetic variants ...
The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.
5don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results